News
Circus SE (XETRA: CA1), a global leader in AI software and embodied AI-robotics for the food service industry, has announced that the European Patent Office has issued the official Decision to Grant ...
Medical announced that European Patent Office, EPO, has granted Patent No. 3,226,792 titled, “Systems And Methods For ...
Computer technology, which includes areas of AI such as machine learning and pattern recognition, led for the first time, with 16,815 patent applications in 2024. Electrical machinery, apparatus ...
On October 31, 2024, the European Commission (the Commission) delivered its long-awaited decision in the Teva Copaxone case (which was published ...
The rise of AI in health care presents new challenges related to the patentability and regulation of AI-driven medical ...
Hosted on MSN22d
European Patent Office declares CureVac mRNA patent valid(Reuters) -The European Patent Office declared a patent owned by CureVac valid, after a challenge from drugmaker BioNTech, the company said on Thursday. U.S.-listed shares of Germany-based CureVac ...
according to the annual Patent Index published on Tuesday by the European Patent Office (EPO). The EPO registered 199,264 patent applications last year, following three years of growth.
Medical and pharmaceutical innovation slows down in Europe, with a decline in patent applications submitted in 2024, a new report reveals.
The European Patent Office (EPO) has issued the official Decision to Grant for Circus SE’s patent securing the core technology behind its AI-robotics system. Covering the device architecture and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results